Printed From BioPortfolio.com
STAT Plus: A second generic drug maker admits to price fixing as part of a far-reaching probe into generics
11:33 EST 4 Dec 2019 | STAT
Rising Pharmaceuticals agreed to pay more than $3 million to resolve criminal and civil charges related to a price-fixing scheme involving a high blood pressure pill.
Original Article: STAT Plus: A second generic drug maker admits to price fixing as part of a far-reaching probe into generics
More From BioPortfolio on "STAT Plus: A second generic drug maker admits to price fixing as part of a far-reaching probe into generics"
Quick Links
Advanced Search |
Login |
Subscribe |
RSS 
Quick Search
BioPortfolio Twitter Channels (200+ Accounts)
LinkedIn